Trulieve: Analysts Expect Beat On Company Full Year Guidance

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their fourth quarter and year-end financials pre-market on March 23rd. Analysts have a consensus C$65.83 12-month price target on the company, via a total of 14 analysts, with two analysts have strong buy ratings and the other 12 have buy ratings. The street high comes from Stifel-GMP with a C$107 price target, and the lowest target comes from Echelon Wealth with a C$43 price target.

Twelve analysts have revenue estimates for the fourth quarter. The mean between all 12 is U$162.49 million; this number has been revised upwards from U$159.35 million at the start of the year. Stifel-GMP currently has the highest revenue estimate with U$170.87 million, while the lowest comes from PI Financial with a U$153.25 estimate.

For the full year, management has guided for revenues between U$465 – U$485 million, but the average estimate between 14 analysts is currently U$513.59 million. This number has been revised upwards from U$511.55 million at the start of the year. The street high comes from Stifel-GMP with a U$523.95 full-year revenue estimate.

Onto EBITDA estimates, there are currently 12 analysts who have fourth-quarter EBITDA estimates. The mean is currently U$75.56 million, with this number being revised upwards from U$72.46 million at the start of the year. Street high goes to Needham with a U$81.30 million EBITDA estimate and the lowest being PI Financial with a U$68.87 million estimate.

For the full-year management has also provided guidance for EBITDA in the range of U$205 – U$225 million. The current EBITDA means across 13 analysts is U$252.47 million, with that number basically staying flat year-to-date. Needham currently has the highest full-year estimate at U$258.80 million.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

CBS News Cuts Staff and Shuts Radio Network in Early Bari Weiss Era

Related News

Trulieve Sets Sights On West Virginia, Sees Grow Facility Approved

Trulieve Cannabis (CSE: TRUL) apparently has West Virginia on its mind. It was reported yesterday...

Friday, August 21, 2020, 09:46:19 AM

Trulieve Appoints Acquired Harvest Health Executives To Leadership Team

Trulieve Cannabis (CSE: TRUL) announced on Tuesday major changes to its executive leadership team. This follows...

Wednesday, December 29, 2021, 01:06:00 PM

Trulieve Files Form S-1 As Part Of Transition To U.S. Reporting Company

Trulieve Cannabis Corp (CSE: TRUL) this morning announced the filing of a resale registration statement...

Wednesday, January 13, 2021, 07:40:56 AM

Trulieve Crosses $1.0 Billion Revenue Mark In 2022, Reports Net Loss

Trulieve Cannabis (CSE: TRUL) this morning reported its delayed fourth quarter financial results. The results...

Wednesday, March 8, 2023, 07:55:00 AM

Trulieve Sues Ex-CFO For Using Firm’s Funds As “Personal Slush Fund”

Trulieve Cannabis (CSE: TRUL) has taken legal action against its former financial chief, Alex D’Amico,...

Friday, March 15, 2024, 11:50:00 AM